SCHEMBL14213564

SCHEMBL14213564

O=C1/C(=C/C=C/c2ccccc2)SC(=S)N1c1ccc(O)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.78
ALDH1A1 P00352 6/20 0.78
POLB P06746 4/20 0.78
HTT P42858 2/20 0.78
LMNA P02545 2/20 0.78
PTPN1 P18031 1/20 0.78
MEN1 O00255 6/20 0.68
KMT2A Q03164 6/20 0.68
L3MBTL1 Q9Y468 4/20 0.68
ALPG P10696 2/20 0.68
RECQL P46063 2/20 0.68
MCL1 Q07820 2/20 0.68
KDM4E B2RXH2 2/20 0.68
USP2 O75604 2/20 0.68
BLM P54132 2/20 0.68
ALPL P05186 1/20 0.68
ALPI P09923 1/20 0.68
APEX1 P27695 1/20 0.68
NPC1 O15118 2/20 0.67
TDP1 Q9NUW8 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213563 0.91 MAPT (0.79) MAPTALDH1A1POLBHTTLMNA
SCHEMBL6738029 0.88 MAPT (1.00) MAPTALDH1A1POLBHTTLMNA
SCHEMBL14213565 0.84 MAPT (0.70) MAPTALDH1A1POLBHTTLMNA
SCHEMBL18313731 0.80 ALDH1A1 (0.64) MAPTALDH1A1POLBHTTLMNA
SCHEMBL14146544 0.80 ALDH1A1 (0.64) MAPTALDH1A1POLBHTTLMNA
SCHEMBL10035969 0.79 MEN1 (0.73) MAPTALDH1A1POLBLMNAMEN1
SCHEMBL4918105 0.78 MAPT (0.61) MAPTALDH1A1POLBHTTLMNA
SCHEMBL30014988 0.78 MAPT (0.61) MAPTALDH1A1POLBHTTLMNA
SCHEMBL4918099 0.78 MAPT (0.61) MAPTALDH1A1POLBHTTLMNA
SCHEMBL6739345 0.76 MAPT (0.78) MAPTALDH1A1POLBHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108677-A1 Thioxothiazolidinone Compounds For Use As Pharmaceuticals KARYON-CTT LTD (FI) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108677-A1 Thioxothiazolidinone Compounds For Use As Pharmaceuticals ITGAM, ITGB1, ITGA1 MAPT 1926/4885ALDH1A1 330/4885POLB 4182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.